- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PD-L1;
Total 5794 results
-
The First People's Hospital of LianyungangRecruitingLung NeoplasmsChina
-
Monika Joshi, MDAstraZenecaActive, not recruiting
-
Elpiscience Biopharma, Ltd.TerminatedNeoplasms | Solid Tumors | Malignant TumorChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Medical University of SilesiaMaria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,...RecruitingNewly Diagnosed GlioblastomaPoland
-
Rapa Therapeutics LLCRecruitingBreast Cancer | Head and Neck Cancer | Gastric Cancer | Solid Tumor | Bladder Cancer | Triple Negative Breast Cancer | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Malignant Melanoma | Carcinoma of Unknown Primary | Squamous Cell Carcinoma of Larynx | Squamous Cell Carcinoma of Oral Cavity | Squamous Cell Carcinoma of Nasopharynx and other conditionsUnited States
-
Tongji HospitalZhejiang Cancer Hospital; Xiangya Hospital of Central South University; Beijing... and other collaboratorsNot yet recruitingCervical Cancer | Locally Advanced Cervical Cancer | PD-L1 Negative | Neoadjuvant ChemoimmunotherapyChina
-
University of Colorado, DenverAstraZenecaWithdrawnPancreatic CancerUnited States
-
Bristol-Myers SquibbWithdrawnMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelogenous Leukemia
-
AstraZenecaRecruitingBiliary Tract CancerFrance, Spain, Italy, Korea, Republic of, Japan, United States, Germany, Singapore
-
Cancer Institute and Hospital, Chinese Academy...UnknownDiffuse Large B-Cell Lymphoma | Sintilimab | TP53 Mutation
-
Hebei Medical University Fourth HospitalActive, not recruiting
-
Xiaohua ZhuRecruitingNSCLC Stage IV | PD-L1 Gene AmplificationChina
-
Leiden University Medical CenterRadboud University Medical Center; AstraZeneca; University Medical Center Groningen and other collaboratorsActive, not recruitingUterine Neoplasms | Endometrial Neoplasms | Endometrium CancerNetherlands
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin LymphomaUnited States, Brazil, Colombia, Czechia, France, Germany, Greece, Guatemala, Italy, Korea, Republic of, Mexico, Netherlands, Slovakia, South Africa, Spain, United Kingdom
-
Fondazione Ricerca TraslazionaleUnknownCarcinoma, Non-Small-Cell Lung
-
EMD Serono Research & Development Institute, Inc.CompletedCarcinoma, Merkel CellUnited States, Spain, Australia, Italy, Germany, France, Japan
-
Merck Sharp & Dohme LLCTerminatedNeoplasms | Head and Neck Neoplasms | Colorectal NeoplasmsAustralia, Hong Kong
-
Hospital of Stomatology, Wuhan UniversityRecruitingClinical IVb Stage Oral Squamous Cell Carcinomas PatientsChina
-
NSABP Foundation IncHoffmann-La Roche; Genentech, Inc.Active, not recruitingTriple Negative Breast CancerUnited States, Canada
-
Sichuan UniversityChengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingSmall Cell Lung Cancer Extensive Stage
-
Sun Yat-sen UniversityWest China Hospital; Nanfang Hospital, Southern Medical UniversityNot yet recruitingNasopharyngeal Carcinoma | Nasopharyngeal CancerChina
-
St. Jude Children's Research HospitalPfizer; Gateway for Cancer ResearchCompletedOsteosarcomaUnited States
-
AstraZenecaActive, not recruitingNon-Small-Cell Lung Carcinoma NSCLCUnited States, Belgium, Spain, Canada, Taiwan, Thailand, Vietnam, France, Germany, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, Netherlands, Australia, Switzerland
-
Agenus Inc.Terminated
-
Merck Sharp & Dohme LLCTerminated
-
Peking UniversityNot yet recruiting
-
Merck Sharp & Dohme LLCCompleted
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCPoland, Taiwan, Thailand, Vietnam, United States, Korea, Republic of, Hungary, Russian Federation, Turkey, China, Australia, Netherlands
-
Olivia Newton-John Cancer Research InstituteAustin Health; Merck Healthcare KGaATerminated
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid TumorsUnited States, Korea, Republic of, Taiwan, France, United Kingdom, Belgium, Czechia, Germany, Poland
-
NanoMab Technology (UK) LimitedKing's College London; Guy's and St Thomas' NHS Foundation TrustRecruiting
-
Sichuan UniversityInnovent Biologics (Suzhou) Co. Ltd.Completed
-
Effector TherapeuticsCompleted
-
Johannes Gutenberg University MainzMerck KGaA, Darmstadt, GermanyCompleted
-
AstraZenecaDaiichi SankyoRecruitingBreast CancerChina, United States, Italy, Spain, United Kingdom, Korea, Republic of, Canada, Germany, Poland, Belgium, Japan, Vietnam, Bulgaria, France, Brazil, India, Malaysia, Taiwan, Thailand, Hungary, Australia, Austria, Turkey, Hong Kong, Switz... and more
-
University of LeipzigRecruitingHepatocellular CarcinomaGermany
-
Shanghai Zhongshan HospitalRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced Solid TumorsChina
-
Guy's and St Thomas' NHS Foundation TrustNanoMab Technology (UK) LimitedRecruitingMelanoma | Non-small Cell Lung CancerUnited Kingdom
-
University of Texas Southwestern Medical CenterAstraZenecaTerminatedFallopian Tube Cancer | Primary Peritoneal Carcinoma | Recurrent Epithelial Cancer of OvaryUnited States
-
Kiang Wu HospitalCompleted
-
Greg Durm, MDMerck Sharp & Dohme LLC; Big Ten Cancer Research ConsortiumCompleted
-
Karolinska University HospitalRecruitingMetastatic Triple-Negative Breast CarcinomaSweden
-
AstraZenecaActive, not recruitingNon-muscle-invasive Bladder CancerFrance, Spain, Belgium, Canada, Poland, Germany, Japan, Russian Federation, United Kingdom, Austria, Australia, Netherlands
-
Checkpoint Therapeutics, Inc.Novotech (Australia) Pty LimitedRecruitingMelanoma | Renal Cell Carcinoma | Head and Neck Cancer | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Non Hodgkin Lymphoma | Endometrial Cancer | Carcinoma, Small Cell | Urothelial Carcinoma | Classical Hodgkin Lymphoma | Merkel Cell Carcinoma | Cutaneous Squamous Cell Carcinoma | Malignant Mesothelioma, AdvancedAustralia, New Zealand, Thailand, Ukraine, Spain, Russian Federation, France, Poland, South Africa
-
The First Hospital of Jilin UniversityRecruitingPD-L1 Positive Locally Advanced Patients With Resectable Gastric CancerChina
-
Institute of Oncology LjubljanaUniversity of Ljubljana; Military Medical Academy, Belgrade, SerbiaRecruitingMetastatic Melanoma | Immune Checkpoints Inhibitors | Gastrointestinal Microbiome (Bacterial and Viral) | Exosomal mRNA Expression of PD-L1 and IFNγSlovenia